ROBERT GERVAIS: Open Payments
NPI 1255326963 · SURPRIZE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 37 payments from 15 companies in 2025. Trend: 2023 $1,037 · 2024 $906 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Endologix LLC | 1 | $137 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $104 |
| Abbott Laboratories | 3 | $68 |
| Novo Nordisk Inc | 3 | $67 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Boston Scientific Corporation | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
Products named: ENDOCROSS Device, LifeVest, ELIQUIS, Wegovy, VERQUVO, LEQVIO, JARDIANCE, General - Vascular Intervention.
Industry payments across AZ — which companies pay providers there.
